Elisa Rita Ceresola1, Silvia Nozza2, Michela Sampaolo3, Angela Rosa Pignataro3, Diego Saita3, Roberto Ferrarese3, Marco Ripa2, Wenjie Deng4, James I Mullins4, Enzo Boeri3, Giuseppe Tambussi2, Antonio Toniolo5, Adriano Lazzarin6, Massimo Clementi1, Filippo Canducci7. 1. University Vita-Salute San Raffaele, Milan, Italy Laboratory of Microbiology, Ospedale San Raffaele, IRCCS, Milan, Italy. 2. Department of Infectious and Tropical Diseases, Ospedale San Raffaele, IRCCS, Milan, Italy. 3. Laboratory of Microbiology, Ospedale San Raffaele, IRCCS, Milan, Italy. 4. Department of Microbiology, University of Washington, Seattle, WA, USA. 5. University of Insubria Medical School, Department of Biotechnology and Life Sciences, Varese, Italy. 6. University Vita-Salute San Raffaele, Milan, Italy Department of Infectious and Tropical Diseases, Ospedale San Raffaele, IRCCS, Milan, Italy. 7. Laboratory of Microbiology, Ospedale San Raffaele, IRCCS, Milan, Italy University of Insubria Medical School, Department of Biotechnology and Life Sciences, Varese, Italy canducci.filippo@gmail.com.
Abstract
OBJECTIVES: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 coreceptor (R5-tropic), 3%-19% of subjects also harbour CXCR4-using viruses (X4-tropic), making tropism determination before CCR5 antagonist usage mandatory. Genotypic methods can be used to accurately determine HIV-1 tropism in chronically infected patients. METHODS: We compared the results of genotypic methods [geno2pheno, PSSMx4r5 including a novel nucleotide-input version (ntPSSM) and distant segments (ds)Kernel] to predict coreceptor usage in a cohort of 67 PHIs. Specimens with discrepant results were phenotypically tested after cloning the V3 gene region into proviral backbones. Recombinant viruses were used to infect U87 indicator cell lines bearing CD4 and either CCR5 or CXCR4. RESULTS: Geno2pheno10%, PSSMx4r5 and (ds)Kernel gave identical predictions in 85% of cases. Geno2pheno10% predicted the presence of CXCR4 viruses in 18% of patients. Two patients were predicted to carry X4-tropic viruses by all algorithms and X4-tropic viruses were detected in at least one of the recombinant AD8 or NL4-3 backbone-based assays. Ten samples resulted in discordant predictions with at least one algorithm. Full concordance between tropism prediction by using population sequencing and phenotypic assays was observed only with ntPSSM. Geno2pheno prediction and the phenotypic assay gave the same results in a minority of 'discordant' patients. CONCLUSIONS: Compared with both PSSMx4r5 versions, (ds)Kernel and our phenotypic assay, geno2pheno10% overestimated the frequency of X4-tropic viruses (18% versus 3%). ntPSSM was able to detect one additional X4 virus compared with (ds)Kernel that was confirmed with the phenotypic assay.
OBJECTIVES: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 coreceptor (R5-tropic), 3%-19% of subjects also harbour CXCR4-using viruses (X4-tropic), making tropism determination before CCR5 antagonist usage mandatory. Genotypic methods can be used to accurately determine HIV-1 tropism in chronically infectedpatients. METHODS: We compared the results of genotypic methods [geno2pheno, PSSMx4r5 including a novel nucleotide-input version (ntPSSM) and distant segments (ds)Kernel] to predict coreceptor usage in a cohort of 67 PHIs. Specimens with discrepant results were phenotypically tested after cloning the V3 gene region into proviral backbones. Recombinant viruses were used to infect U87 indicator cell lines bearing CD4 and either CCR5 or CXCR4. RESULTS:Geno2pheno10%, PSSMx4r5 and (ds)Kernel gave identical predictions in 85% of cases. Geno2pheno10% predicted the presence of CXCR4 viruses in 18% of patients. Two patients were predicted to carry X4-tropic viruses by all algorithms and X4-tropic viruses were detected in at least one of the recombinant AD8 or NL4-3 backbone-based assays. Ten samples resulted in discordant predictions with at least one algorithm. Full concordance between tropism prediction by using population sequencing and phenotypic assays was observed only with ntPSSM. Geno2pheno prediction and the phenotypic assay gave the same results in a minority of 'discordant' patients. CONCLUSIONS: Compared with both PSSMx4r5 versions, (ds)Kernel and our phenotypic assay, geno2pheno10% overestimated the frequency of X4-tropic viruses (18% versus 3%). ntPSSM was able to detect one additional X4 virus compared with (ds)Kernel that was confirmed with the phenotypic assay.
Authors: Timothy Cardozo; Tetsuya Kimura; Sean Philpott; Barbara Weiser; Harold Burger; Susan Zolla-Pazner Journal: AIDS Res Hum Retroviruses Date: 2007-03 Impact factor: 2.205
Authors: E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss Journal: Nature Date: 1998-01-15 Impact factor: 49.962
Authors: Tobias Sing; Andrew J Low; Niko Beerenwinkel; Oliver Sander; Peter K Cheung; Francisco S Domingues; Joachim Büch; Martin Däumer; Rolf Kaiser; Thomas Lengauer; P Richard Harrigan Journal: Antivir Ther Date: 2007
Authors: M T Roos; J M Lange; R E de Goede; R A Coutinho; P T Schellekens; F Miedema; M Tersmette Journal: J Infect Dis Date: 1992-03 Impact factor: 5.226
Authors: Oliver Sander; Tobias Sing; Ingolf Sommer; Andrew J Low; Peter K Cheung; P Richard Harrigan; Thomas Lengauer; Francisco S Domingues Journal: PLoS Comput Biol Date: 2007-02-08 Impact factor: 4.475
Authors: Katlego Sojane; Richard T Kangethe; Christina C Chang; Mahomed-Yunus S Moosa; Sharon R Lewin; Martyn A French; Thumbi Ndung'u Journal: AIDS Res Hum Retroviruses Date: 2018-05-23 Impact factor: 2.205
Authors: Anh Q Le; Jeremy Taylor; Winnie Dong; Rosemary McCloskey; Conan Woods; Ryan Danroth; Kanna Hayashi; M-J Milloy; Art F Y Poon; Zabrina L Brumme Journal: Sci Rep Date: 2015-12-03 Impact factor: 4.379